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Abstract
Antibiotic surveillance initiatives are limited in resource-constrained settings. In the present study, a quantitative
comparison of antibiotic use rates for suspected infections in 2 hospitals in India was performed using the ‘‘focus of
infection’’ approach to identify targets for quality improvement in antibiotic prescription patterns in hospitalized patients.
Methods: This observational study was carried out in one teaching and one nonteaching hospital. All the patients with
suspected bacterial etiology were included. Data on the prescribed antibiotics and the focus of infection were prospectively
collected using a structured questionnaire. Each diagnosis was further reviewed and confirmed by an independent
consultant. The prescribed antibiotics were coded according to the World Health Organization Anatomic Therapeutic
Classification (ATC) index with the defined daily dose (DDD) methodology. Focus-specific DDDs were calculated per
hundred patient days (DDD/HPD).
Results: A total of 6026 patients were included from 72 participating physicians out of available 75 physicians. Overall
antibiotic prescribing was higher by 5 percentage points in the teaching hospital (95%) than in the nonteaching hospital
(90%). Quinolones (ciprofloxacin constituting 86% of DDD/HPD) were the highest prescribed class in the teaching hospital,
and third-generation cephalosporins (with ceftriaxone and ceftriaxone/sulbactam constituting 40% and 28% of the DDD/
HPD, respectively), in the nonteaching hospital. The targets identified for improvement were the following: longer than
recommended duration of prophylaxis and lack of distinction between prophylaxis and therapy among surgical patients;
irrational antibiotic prescribing in gastroenteritis; overuse of quinolones and lack of use of penicillin in pneumonia; overuse
of quinolones and lack of use of doxycycline and macrolides in genital infections; and overreliance on antibiotics for treating
skin and soft tissue infections.
Conclusions: Providing a quantitative comparison of antibiotic use rates for suspected infections, using the ‘‘focus of
infection’’ approach along with the ATC/DDD methodology, appears appropriate for identifying targets for quality
improvement with regards to antibiotic prescribing.
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Introduction
Antibiotic resistance is a rapidly increasing public health
problem [1]. Although most of the evidence is at an ecological
level, it is widely accepted that the most potent driver for antibiotic
resistance is antibiotic use [2]. The availability and use of the
World health Organization (WHO) Anatomic Therapeutic
Clinical classification and defined daily dose (ATC/DDD)
methodology facilitate meaningful comparisons of antibiotic
consumption across hospitals and also between countries [3]. An
increase in the use of antibiotics in hospital settings has been
documented worldwide, with a simultaneous increase in resistance
and spread of resistant strains of many bacteria [4–7].
Disease surveillance projects have been initiated in several
countries, and national antibiotic policies have been formulated.
These projects, which used the ATC/DDD methodology, include
Strama in Sweden [8], Danish Integrated Antimicrobial Resis-
tance Monitoring and Research Programme (DANMAP) in
Denmark [9], Dutch Working Party on Antibiotic Policy (Dutch
acronym is SWAB) [10], Surveillance of Antibiotic Use and
Resistance in Intensive Care (SARI) or Medical Antibiotic Use
Surveillance and Evaluation (MABUSE) in Germany [11],
European Surveillance of Antimicrobial Consumption (ESAC) in
Europe [4,12] and Intensive Care Antimicrobial Resistance
Epidemiology (ICARE) in the United States [13]. However, there
is a serious lack of similar initiatives in resource-constrained
settings, where the burden of infections requiring effective
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38641antibiotics is higher [1,7]. Because the cost of health care for
resistant infections is high, injudicious use of antibiotics is a greater
public health problem with respect to quality of patient care in
resource-constrained settings. The National Centre for Disease
Control, under the Director General of Health Services, Ministry
of Health and Family Welfare, Government of India, published
The National Policy for Containment of Antimicrobial Resistance, India in
2011 [14]. However, there are surprisingly few published reports
describing the use of antibiotics in hospitals in India using the
WHO ATC/DDD methodology. This lack of information hinders
discussion of targeted interventions to reduce irrational antibiotic
prescribing.
Accurate evaluation of antibiotic use can be achieved using
patient-level surveillance [15]. However, even in the presence of
accurate computerized prescription data, linking prescribing
information to a given patient or diagnosis might not be possible.
Extracting information from handwritten case records is time-
consuming. In many resource-constrained settings, medical
records are poorly maintained, leading to underestimation and
misclassification of the underlying etiology associated with the
prescription of antibiotics [16]. We have attempted to address
these methodological challenges in the present study by using the
‘‘focus of infection’’ approach, along with the WHO ATC/DDD
methodology, to study hospital antibiotic prescribing in a resource-
constrained setting. The aim of this study was to provide a
quantitative comparison of antibiotic use rates for suspected
infections, using the ‘‘focus of infection’’ approach to identify
targets for quality improvement with regard to antibiotic
prescribing, taking 2 hospitals in Ujjain, India, as examples.
Methods
Study settings
The study sites were 2 hospitals. One is a 570-bed teaching
hospital attached to the RD Gardi Medical College, which is a
nonpaying facility located approximately 6 kilometers from the
city of Ujjain. The consultants in this hospital have an institutional
hospital-based practice and are not allowed to work in private
practice. The other hospital is a 330-bed nonteaching hospital
located in the city of Ujjain. In this hospital, all services are
charged, but the hospital is run on a break-even basis. The
consultants in the nonteaching hospital are allowed to work in
private clinics outside of their official hours of work. Both hospitals
cater predominantly to a rural population from the villages
surrounding Ujjain city. In both hospitals, most admissions (91%)
in medical and intensive care units are emergency admissions,
whereas in the surgical units, both elective and emergency
admissions are equally common. Treatment guidelines for
infectious diseases have not been implemented in either hospital.
Study participants
All the patients in whom the admitting consultant suspected an
infectious etiology at the time of admission or during the hospital
stay and for which antibiotic therapy was started were included in
the study. The patients admitted for infectious etiologies requiring
anti-infective agents other than antibiotics and those treated for
tuberculosis were not included.
The participating departments or units in both hospitals were
the departments of pediatrics, including the neonatal intensive
care unit; general medicine, including the medicine intensive care
unit; general surgery; obstetrics and gynecology; ear, nose, and
throat; and orthopedics. A total 72 physicians out of available 75
from the above-mentioned departments participated in the study,
a participation rate of 96%. Participation was voluntary.
Sample size
The sample size calculation was based on a pilot study done in
March and May 2007, which estimated that between 80 and 90%
of all the admitted patients were prescribed antibiotics. Assuming a
prevalence of 80% for antibiotic prescribing and requesting 80%
power to detect a difference of 10 percentage points between
hospitals for a given focus of infection in a statistical test for the
comparison of 2 proportions with a 5% significance level, the
required sample size was 108 in each of the focus of infection to be
compared. Since, we had 15 foci of infection to be compared the
minimum sample size was 15 X 108 X 2=3240 patients.
Data collection form and procedure
The data collection form included patient details, age, sex,
admission ward, dates of admission, discharge, prescribed
antibiotic (s) (classified according to ATC), start and completion
of antibiotic treatment course, dose per administration, number of
doses per day, and route of administration. Any change in the
antibiotic prescribed, its dose, or duration was noted. The final
diagnosis was coded according to the targeted anatomical systems
or subsystems identified as ‘‘focuses of infection’’ (Table 1) [4,17].
Examples of typical infections in each group are also listed. The
same diagnosis codes were used for surgical prophylaxis and for
therapy. The duration of therapy for surgical prophylaxis was
noted as single dose, single day, or more than 1 day.
The questionnaire was attached to the inpatient files of all the
admitted patients. The admitting consultant filled in the diagnosis
codes. Each focus of infection was categorized into 1 of 3
indications for therapy or prophylaxis: (a) community-acquired
infection; (b) hospital-acquired infection (for definition, see table 1);
or (c) perioperative or medical prophylaxis.
The resident medical officers of the participating departments
filled in the details of antibiotics prescribed by following up each
patient from admission until discharge. A second independent
consultant reviewed all the forms and also discussed and resolved
any controversies regarding the focus of infection. The clinical
suspicion of a focus of infection was confirmed by appropriate
hematological, biochemical, and radiological investigations.
The structured questionnaire used in the present study was
adapted from the Strama point prevalence surveys and ESAC
[4,17]. The final form was pilot tested twice in March and May
2007 on 100 patients each in both hospitals.
Each patient admission was counted only once, and patient
transfers between units of a hospital were not counted as separate
admissions. A patient’s duration of stay was calculated by
subtracting the date of admission from the date of discharge.
The days of admission and discharge were counted together as 1
day. The same data collection form and procedure were used in
both hospitals. Only 1 focus of infection, which was considered as
the most relevant for therapy or prophylaxis, was included.
Duration of data collection
Data collection was done from November 2007 to February
2009. The data were collected for 45 days in each hospital. A gap
of 15 days was introduced between the 2 hospitals and every 4
months to allow time for appropriate data management. The study
period covered 4 seasons, namely, 2 winters (1 in the beginning
and 1 at the end, November to February), 1 summer (March to
June), and the rainy season (July to October).
Data management and statistical analysis
Each prescribed antibiotic was coded according to the WHO
Collaborating Centre for Drug Statistics Methodology, ATC
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fifth level in J01 (antibacterial for systemic use). Nitroimidazole
derivatives (P01AB) and nitazoxanide (P01AX11) were also
included. Focus-specific DDDs were calculated per hundred
patient days (DDD/HPD). The DDD/HPD of a given focus of
infection was compared to study the antibiotic prescribing pattern
of the 2 hospitals.
The data were entered into the EpiData Entry (version 3.1) and
then transferred to the Stata 10.0 for further analysis (Stata Corp.,
College Station, Texas, USA). A descriptive data analysis was
conducted to understand the frequency of the patient-related
variables (age groups, sex, services of the hospital, and season), foci
of infection, and prescribed antibiotic and its class. The Pearson
chi-square test was used to test for statistical significance (5%).
Ethics statement
The ethics committee of RD Gardi Medical College approved
the study (approval no. 41/2007). Informed written consent was
obtained from all the patients. The research was conducted
according to the principles expressed in the Declaration of
Helsinki. The study did not interfere with the ongoing treatment
of the patients.
Results
The study included 6026 admitted patients, 2525 (42%) of
whom were women and 3501 (68%) were men; 2352 patients
(39%) were from the teaching hospital, and 3674 (61%) were from
the nonteaching hospital. A total of 5531 patients (92%) were
prescribed antibiotics for various foci of infection. Table 2 shows
the details of the foci of infection recorded for the antibiotic
treatment for the community-acquired infections, hospital-associ-
ated infections (HAI), and prophylaxis. Prophylaxis was given to
1846 patients (34% of the total), and in 86% (n=1593), it was
given for more than 1 day. Eighty-six percent of those on
prophylaxis for more than 1 day belonged to surgical services,
including the departments of general surgery; obstetrics and
gynecology; ear, nose, and throat; and orthopedics. Gastroenter-
itis, pneumonia, bronchitis, central nervous system, and cardio-
vascular system infections and undifferentiated febrile illnesses
were predominantly community-acquired. HAI was identified in
9% of all the infections. The most common HAI recorded was skin
and soft tissue infection due to surgical site infection.
The patient’s age group, sex, the hospital service, and the season
in which the patient was admitted were significantly associated
with antibiotic prescribing (Table 3). Most patients (59%) were
prescribed 1 antibiotic. A combination of 2, 3, or 4 antibiotics was
prescribed significantly more often in the teaching hospital. The
mean length of stay in the teaching hospital was 7.8 days (95%
confidence interval [CI] 7.3–8.3 days) and that in the nonteaching
hospital was 4.2 days (95% CI 4.1–4.4 days).
Focus of infections
Gastroenteritis. In the teaching hospital, the prescribed
antibiotics were ciprofloxacin (72 DDD/HPD), metronidazole (35
DDD/HPD), and cefotaxime (35 DDD/HPD). In the nonteach-
ing hospital, ceftriaxone (40 DDD/HPD), ceftriaxone/sulbactam
(4 DDD/HPD), ciprofloxacin (22 DDD/HPD), ofloxacin
(20DDD/HPD), and metronidazole (30DDD/HPD) were pre-
scribed (Table 4).
Intra-abdominal (upper and lower gastrointestinal
tracts). The upper and lower gastrointestinal tracts were the
most common sites of infection reported (n=844) in the general
surgery patients. Most of the patients (n=508; 60%) received
Table 1. Details of anatomical system or sub-system identified as focuses of infection with examples of infectious diseases
included in the study in two hospitals in Ujjain.
System/subsystem diagnosed as focus of infection List of infections included in each focus of infection
CNS Meningitis, meningo-encepalitis
Eye Conjunctivitis, opthalmitis, retinitis etc
Ear, nose and throat, down to larynx Tonsillitis, peritonsillitis, otitis, mastoiditis etc.
Bronchitis
Pneumonia Including pneumonia with septicemia,
CVS Endocarditis, phlebitis, pericarditis
Upper gastrointestinal tract to terminal ileum Peri operative prophylaxis, peritonitis, including H pylori
Lower gastrointestinal tract Peri operative prophylaxis, peritonitis, intra-abdominal abscess of unknown origin, diverticulitis
Gastroenteritis Gastro- intestinal tract, contagious diseases like Salmonella, Shigella, Vibrio cholerae etc.
Liver, biliary tract and pancreas Hepatitis, cholecystitis etc.
Skin and soft tissue Wound infections including post operative, erysipelas, deep infections, gangrene, myositis
Bone and joint Osteomyelitis, arthritis etc
Renal Pyelonephritis, febrile UTI, including uncomplicated urosepsis
Genital infections Pelvic inflammatory disease, salpingitis, prostatitis, orchitis etc
Septicemia Clinical evidence of sepsis
FUO/UFI Focus of infection not identified
Unclear Completely unclear indication
Health-care associated infection Any infection resulting from any treatment or investigation associated with health care, regardless of
whether the causing agent originates from the patient or the hospital environment
GIT gastrointestinal tract, FUO fever of unknown origin, UFI undifferentiated febrile illness, SSTI skin and soft tissue infections, ENT ear, nose and throat, CNS central
nervous system, CVS cardiovascular system.
doi:10.1371/journal.pone.0038641.t001
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24 hours post surgery.
In the teaching hospital, nitroimidazoles were the most common
antibiotics prescribed (122 DDD/HPD; DDD contribution:
metronidazole 86%, tinidazole 12%, and ornidazole 2%), followed
by quinolones (83 DDD/HPD-ciprofloxacin 88%, ofloxacin 10%,
and norfloxacin 2%), tetracycline, and third-generation cephalo-
sporins (Table 4).
In the nonteaching hospital, third-generation cephalosporins
(93DDD/HPD-ceftriaxone 45%, ceftriaxone/sulbactam 42%,
cefotaxime 8%, and ceftazidime 5%) were the commonest
antibiotic class prescribed, followed by nitroimidazole (83DDD/
HPD-metronidazole 68%, tinidazole 18%, ornidazole 9%, and
nitazoxanide 5%; Table 4). Children were prescribed newly
marketed nitazoxanide more often.
Respiratory (pneumonia and bronchitis). In the teaching
hospital, pneumonia was most commonly treated with tetracy-
clines (69 DDD/HPD-doxycycline 63% and tetracycline 37%),
followed by quinolones (42 DDD/HPD-ciprofloxacin 94% and
levofloxacin 5%), penicillins with extended spectrum (41 DDD/
HPD-ampicillin with cloxacillin 76%, ampicillin 18%, amoxicillin
6%), and third-generation cephalosporins (22 DDD/HPD-cefo-
taxime 66% and ceftriaxone 24%); co-trimoxazole was also
commonly prescribed. In the nonteaching hospital, third-genera-
tion cephalosporins (57 DDD/HPD-ceftriaxone with beta-lacta-
mase inhibitor 56%, ceftriaxone 28%, and cefotaxime 12%),
quinolones (32 DDD/HPD-ciprofloxacin 68% and levofloxacin
22%), and co-amoxiclav were prescribed.
The prescribing pattern for bronchitis was similar to that for
pneumonia in the respective hospitals (Table 4 and Figure 1).
Renal infections. In the treatment of renal infections, the
antibiotic prescribing pattern was similar in the 2 hospitals. The
quinolones, third-generation cephalosporins, and aminoglycosides
were the most common classes prescribed. In the nonteaching
hospital, however, a greater proportion of levofloxacin, ceftriaxone
with a beta-lactam inhibitor, amikacin, and nitelmycin were
prescribed (Table 4).
Genital infections. In the patients with genital infections
(98% women), higher amounts of DDD/HPD were prescribed in
the nonteaching hospital than in the teaching hospital (Table 4). In
the teaching hospital, the most common antibiotics prescribed
were quinolones (55 DDD/HPD-ciprofloxacin 64% and norflox-
acin 33%), followed by penicillins with extended spectrum (53
DDD/HPD-ampicillin with cloxacillin 62%, ampicillin 33%, and
amoxicillin 4%), nitroimidazoles (45 DDD/HPD-metronidazole
86%), and third-generation cephalosporins (39 DDD/HPD-
cefotaxime 62% and ceftriaxone 32%). In the nonteaching
hospital, third-generation cephalosporins (129DDD/HPD-cefo-
taxime 55%) and quinolones (61 DDD/HPD-ciprofloxacin 70%)
were prescribed. Aminoglycosides and nitroimidazoles were
prescribed often in combination with third-generation cephalo-
sporins and quinolones.
Skin and soft tissue, bone, and joint infections. In both
hospitals, skin and soft tissue infection (SSI) was most commonly
treated with co-trimoxazole (1361 DU/HPD in the teaching
hospital versus 236 DU/HPD in the nonteaching hospital). In the
teaching hospital, aminoglycosides (58 DDD/HPD-gentamicin
65% and 32% amikacin), third-generation cephalosporins (44
DDD/HPD-cefotaxime 45% and ceftriaxone 34%), nitroimida-
zoles, and quinolones were prescribed (Table 4).
In the nonteaching hospital, the most common class prescribed
was third-generation cephalosporins (92 DDD/HPD-ceftriaxone
36% or ceftazidime with beta-lactamase inhibitor 20%), followed
by nitroimidazoles (37 DDD/HPD-metronidazole 69% and
tinidazole 22%), aminoglycosides (35 DDD/HPD), and quino-
Table 2. Focuses of infection recorded for antibiotic treatment for community acquired and hospital-associated infections and for
prophylaxis.
No (%) of patients treated for
Focus of infection
Total no of patients
(n=5531)
Community Acquired
Infections
(n=3168) (57%)
Hospital Associated
Infections
(n=517) (9%)
Prophylaxis
(n=1846) (34%)
Gastroenteritis 232 223 (96) 0 9 (4)
Upper and lower GIT 844 260 (31) 76 (9) 508 (60)
Liver, biliary tract and pancreas 133 78 (59) 18 (14) 37 (28)
Pneumonia 611 568 (93) 9 (3) 24 (4)
Bronchitis 191 174 (91) 6 (3) 11 (6)
Genital infections 665 173 (26) 51 (8) 441 (66)
FUO/UFI 559 445 (80) 30 (5) 84 (15)
Renal 495 218 (44) 79 (16) 198 (40)
SST 481 95 (20) 133 (28) 253 (53)
ENT and eye 291 192 (66) 8 (3) 91 (31)
CNS 262 232 (89) 22 (8) 8 (3)
Bone and joint infections 253 48 (19) 35 (14) 170 (67)
CVS 244 229 (94) 12 (5) 3 (1)
Sepsis 229 195 (85) 26 (11) 8 (3)
Unclear 41 38 (93) 2 (5) 1 (2)
GIT gastrointestinal tract, FUO fever of unknown origin, UFI undifferentiated febrile illness SSTI skin and soft tissue infections, ENT ear, nose and throat, CNS central
nervous system, CVS cardiovascular system.
doi:10.1371/journal.pone.0038641.t002
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Table 4).
For the treatment of bone and joint infections, the pattern of
antibiotic prescribing was similar in the 2 hospitals (Table 4 and
Figure 1), with third-generation cephalosporins, quinolones, and
aminoglycosides being the top 3 classes prescribed (Table 4).
Discussion
To the best of our knowledge, this is the first study to use the
‘‘focus of infection’’ approach, along with the WHO ATC/DDD
methodology, for quantifying antibiotic prescribing in India. The
DDDs were calculated per 100 patients per focus of infection per
day (DDD/HPD). The results show that more DDD/HPD were
prescribed in the teaching hospital for nearly all the foci of
infections. These findings are similar to those of a large French
study that demonstrated that higher antibiotic DDDs were
dispensed in teaching hospitals [5]. The higher rate of antibiotic
use in the teaching hospital in our study could be due to its status
as a referral center for complicated cases, although disease severity
was not monitored in our study. Newly marketed antibiotics like
the combination of third-generation cephalosporins with beta-
lactamases and Nitazoxanide, were prescribed more often in the
non-teaching hospital. Since, in the non-teaching hospital services
are provided for a cost and the teaching hospital is a free-of-cost
facility, the payment status of the hospital is likely to influence the
antibiotic prescribing. In a countrywide study among Irish general
practitioners (GPs) it was found that GP’s decision to provide a
prescription for antibiotics might be influenced by whether or not
the patient pays for their consultation {Murphy, 2011}. Combi-
nation antibiotic therapy was more common in the teaching
hospital. However, the combination of third-generation cephalo-
sporins with beta-lactamases, which is not a rational choice, was
used more often in the nonteaching hospital. There is evidence
that monotherapy is sufficient for all serious infections without
shock [18]. Thus, developing guidelines for prudent antibiotic use
for common infections is a priority identified through this study.
Approximately 9% of the infections were classified as HAI,
which is a lower incidence than the expected rate of around 25%
[19]. This might be due to the lack of specific surveillance for
identifying HAIs and also to the lack of awareness of HAI. SSIs
were the most commonly detected HAIs, and 28% of all the SSIs
were surgical site infections. SSI was also a common reason for
surgical prophylaxis. Establishing surveillance for HAI and
specifically for SSI was also identified as a target for quality
improvement in this study.
Approximately one third of all antibiotic prescribing was for
prophylaxis, mainly in surgical services. Most (86%) of these
patients received antibiotics for longer than 24 hours, which is a
cause of concern that should be considered for possible
intervention. Unnecessarily long surgical prophylaxis was also
reported in the ESAC hospital point prevalence studies in 2006,
2008, and 2009 [12].
Variation in antibiotic prescribing according to age groups was
observed in this study, with higher rates (by 4 to 9% unit points) of
antibiotic prescribing in adults than in children. Such variation
Table 3. Patient characteristics and antibiotic prescribing in the two hospitals in Ujjain, India.
Teaching hospital Non-teaching
Patient
characteristics
Total Patients
N=6026
Number of patients
n=2352
% prescribed
antibiotics (95)
Number of patients
n=3674 % prescribed antibiotics (90)
Age group
0–1 month 207 49 88 158 86
1 mo–5 years 539 151 88 388 88
6 years–12 years 294 123 86 171 88
13 years–45 years 3030 1206 95 1824 92
46 years–75 years 1795 765 97 1030 89
More than 75 years 161 58 97 103 90
Sex
Females 2525 1026 95 1449 88
Males 3501 1326 95 2175 91
Services
Paediatrics 686 192 81 492 87
Medical 2313 815 95 1498 90
Surgical 2628 1276 96 1352 90
NICU 192 30 97 162 90
ICU 207 39 97 168 92
Season
(i)
2
nd winter 1302 947 91 806 87
1
st winter 2189 580 96 772 91
Summer 782 587 97 1602 91
Rainy season 1755 238 99 544 90
iThe study period covered four seasons, two winters, one in the beginning of the data collection and one at the end (November to February), summer (March to June)
and the rainy season (July to October).
doi:10.1371/journal.pone.0038641.t003
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diagnosis prescribing study [20].
We analyzed the pattern of antibiotic prescribing in specific foci
of infection. Over prescription of antibiotics for diarrhea is a major
public health problem in India [21]. Acute diarrhea is self-limiting
in most cases, and treatment should be restricted to rehydration,
correction of electrolyte imbalance, and oral zinc for children [21].
Prescription of the nitroimidazole group of antibiotics, especially in
children, cannot be explained rationally. The reasons behind such
prescribing need to be researched, and appropriate, context-
specific interventions need to be introduced.
Prophylactic use of antibiotics is common in patients undergo-
ing surgical procedures [22]. A total of 508 (60%) of 844 patients
received prophylactic antibiotics for prevention of infection
localized to the upper and lower gastrointestinal tract. The most
common antibiotic regimens were ciprofloxacin with metronida-
zole and third-generation cephalosporins with metronidazole in
the teaching and nonteaching hospitals, respectively. Given the
polymicrobial nature of intra-abdominal infections arising from
resident enteric flora, the above-mentioned combination therapy
might be justified but only as a treatment option for source control
[22]. We observed no difference in the antibiotics chosen for
treatment and prophylaxis. In addition, as already discussed, most
prophylaxis continued beyond 24 hours after surgery. The lack of
distinction between the use of antibiotic therapy for prophylaxis
and its use for treatment of an established infection is identified as
an important quality improvement target.
Doxycycline and tetracycline dominated the prescription
pattern for pneumonia in the teaching hospital, and these are
appropriate for community-acquired pneumonia (CAP) of all
severities according to the British Thoracic Society guidelines [23].
The use of ciprofloxacin, which was the second most common
antibiotic prescribed for CAP, is not appropriate especially in view
of its poor activity against Streptococcus pneumoniae and Klebsiella
pneumoniae, the 2 organisms most frequently associated with adult
pneumonia in the Asia-Pacific region [24]. Non-use of penicillin is
a cause of concern, as recent evidence shows that fewer than 5% of
all the nonmeningeal isolates of S. pneumoniae from the Asia-Pacific
are penicillin resistant (according to an MIC of 8 mg/mL) [24].
Convincing physicians to increase use of penicillin is identified as a
key quality improvement issue.
The Infectious Disease Society of America recommends the use
of 1 of the following 3 initial therapies for acute pyelonephritis in
adults: (a) fluroquinolone, (b) aminoglycoside with or without
ampicillin, or (c) extended spectrum cephalosporin with or without
aminoglycoside [25]. The antibiotic prescribing pattern in renal
infections appeared to be appropriate in both hospitals.
There is a significant unmet demand for the treatment of genital
infections among women in rural India due to their high disease
burden [26]. In addition, the skewed urban distribution of health-
care workers contributes to this unmet demand [27]. The
optimization of therapy for hospitalized genital infections (espe-
cially pelvic inflammatory disease) must take into account the
polymicrobial etiology of the disease, the severity of the disease,
and patient compliance with antibiotic use. The optimal treatment
for genital infections should include an antibiotic with activity
against Neisseria gonorrhoeae, Chlamydia trachomatis, and Mycoplasma
genitalium. Because no single agent covers all of these organisms,
combination therapy is recommended [28]. In the teaching
hospital, ciprofloxacin or norfloxacin were prescribed, often in
combination with metronidazole. However, ciprofloxacin is less
effective against bacterial vaginosis-associated microorganisms;
therefore, possible relapse of the infection is of concern. In
addition, increasing quinolone resistance among N. gonorrhoeae
isolates has been documented in the Asia-Pacific region [7]. Third-
generation cephalosporins are a good addition to the regimen
[28], which was used more often in the nonteaching hospital.
Overuse of aminoglycosides and lack of use of doxycycline and
macrolides were identified as quality improvement targets in
antibiotic prescribing for genital infections.
Among hospital patients with SSI, antibiotic therapy should be
initiated only if the patient fails to respond to incision and drainage
or shows abscess with severe and extensive disease, rapidly
progressive cellulitis, signs and symptoms of systemic disease,
associated comorbidities, immunosuppression, or an abscess in an
area difficult to drain (face, neck, or hand) [29]. Most of the
patients treated with antibiotics in the 2 hospitals did not fulfill
these criteria. The most common choice of antibiotic was co-
trimoxazole, which appears appropriate. However, the relatively
common use of quinolones and third-generation cephalosporins is
not justified [29].
The main strength of the present study is that unlike most
surveillance [4,5,6,11,12], which collects and presents dispensing
Figure 1. Wisker box plot comparing the antibiotic classes prescribed in Ujjain, India.
doi:10.1371/journal.pone.0038641.g001
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patients and on antibiotics actually administered to the patients.
Therefore, our data are robust and relevant for interventions and
for monitoring trends. The validity of our data is strong because an
independent expert confirmed the foci of infection. However,
there are a few limitations. The design of the study is resource
intensive, requiring dedicated personnel. We did not evaluate the
severity of illness, which would have further intensified the
workload. The study did not include positive bacterial cultures
or other laboratory measures to confirm the focus of infection, but
would like to do so in our future studies. Monitoring of sensitivity
patterns itself can change prescription patterns. The results are not
strictly comparable within a season, as data were not collected
simultaneously in the 2 hospitals. In the present study we have
focused on choice of antibiotics as the main outcome but other
aspects of rational antibiotic prescribing like duration of treatment
and appropriateness of choice of formulations (for example oral
therapy versus intravenous and use of syrup or tablets) is not
discussed in the study. The expectancy effect i.e. the consultants
under observation changing the rate of antibiotic prescribing, is a
potential bias. However, the prescribing was observed for a longer
duration in this study, thus minimizing the expectancy effect.
Conclusions
Using a data collection procedure that can produce good focus
of infection-specific information on ATC/DDD, we were able to
identify targets for quality improvement in antibiotic prescribing.
The targets identified are higher antibiotic prescribing in a
teaching hospital compared with a nonteaching hospital, longer
than recommended duration of prophylaxis and lack of distinction
between prophylaxis and therapy among surgical patients,
irrational antibiotic prescribing in gastroenteritis, overuse of
quinolones and lack of use of penicillin in pneumonia, overuse
of quinolones and lack of use of doxycycline and macrolides in
genital infections, and overreliance on antibiotics in treating skin
and soft tissue infections. The study provides much needed Indian
data for policy makers to design strategies for promoting prudent
antibiotic use and formulating national, regional, and local
therapeutic guidelines.
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